Takeda Plans Biopharmaceutical R&D Center in Kendall Square
Takeda is partnering with BioMed Realty to create a 600,000-sf R&D center in Cambridge. Designed by CBT Architects, the 16-story facility will provide sophisticated lab and office environments for the discovery of next-generation biopharmaceutical therapies and vaccines. Takeda has executed a 15-year lease for all of the research floors in the building, which will feature flexible spaces that maximize in-person interaction and connection under a hybrid working model.